Research and development
Research Teams working on projects targeting specific therapeutic goals
The I-Stem laboratory is an institution dedicated to the exploration of potential therapeutic applications of human ES cells and therefore, is rather a scientific center focusing on “Research and Development”. The therapeutic target goal is a constant preoccupation which translates into the organisation of teams focused on specific aims and time lines. Such an organisation has enabled us to easily test the "feasibility" of the scientific process since each calendar displays benchmarks, with specific objectives in specified periods.
The nine current scientific programs of I-Stem
We are working on nine major directions, six focusing on research and three working on development. The primary focus of the research teams has been targeting a few monogenic diseases, specifically Huntington, Duchenne, Steinert, and Clouston. These diseases were chosen primarily by the scientific opportunity and will be expanded as the I-Stem Institute increases in size.
The ambition of I-Stem is to develop a technology platform capable of covering all aspects of discovery and development of therapeutic molecules for pre-clinical trials as defined by clinical and epidemiological studies of monogenic diseases, until a candidate molecule is identified for pre-clinical trials.
For research as well as technological development teams, many industrial and academic partnerships have already been established.
